E. C. Hsia
Impact in
- Rheumatology top 2%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
- Hematology top 5%
- Autoimmune and Inflammatory Disorders Research
Papers in
- Rheumatology 28
- Rheumatoid Arthritis Research and Therapies 25
- Spondyloarthritis Studies and Treatments 6
- Systemic Lupus Erythematosus Research 6
- Genetics 7
- Chronic Lymphocytic Leukemia Research 7
- Co-authors
- Mahboob U. Rahman (9 shared papers)Edward Keystone (6 shared papers)Stephen Hall (4 shared papers)Mark C. Genovese (7 shared papers)Pedro C. Miranda (2 shared papers)Sudha Visvanathan (1 shared paper)William Palmer (1 shared paper)Lars Klareskog (3 shared papers)
- Journals
- Annals of the Rheumatic Diseases (24 papers)Value in Health (4 papers)Lara D. Veeken (3 papers)Data Archiving and Networked Services (DANS) (1 paper)DIAL (Catholic University of Leuven) (1 paper)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
E. C. Hsia
28 papers receiving 518 citations
E. C. Hsia's Hit Papers
Peers
Comparison fields: 5 of 38
- Rheumatology 456
- Hematology 134
- Immunology 92
- Genetics 44
- Radiology, Nuclear Medicine and Imaging 58
Countries citing papers authored by E. C. Hsia
This map shows the geographic impact of E. C. Hsia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. C. Hsia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. C. Hsia more than expected).
Fields of papers citing papers by E. C. Hsia
This network shows the impact of papers produced by E. C. Hsia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. C. Hsia. The network helps show where E. C. Hsia may publish in the future.
Co-authors
The 25 scholars most cited alongside E. C. Hsia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study Hit paper breakdown → | 2008 | 432 |
| 2 | 2011 | 61 | |
| 3 | One-year results of golimumab compared with placebo in patients with active RA despite treatment with methotrexate: A phase II, randomized, double-blind, placebo-controlled, dose-ranging trial. | 2006 | 7 |
| 4 | Golimumab, a new human Anti-TNF-alpha monoclonal antibody, administered subcutaneously everv 4 weeks in methotrexate-naive patients with active rheumatoid arthritis: A randomized, double-blind, placebo-controlled, GO-BEFORE study | 2008 | 4 |
| 5 | 2013 | 4 | |
| 6 | GOLIMUMAB SIGNIFICANTLY IMPROVES PHYSICAL FUNCTION AND FATIGUE IN RA PATIENTS PREVIOUSLY TREATED WITH ANTI-TNF AGENTS: RESULTS FROM THE GO-AFTER STUDY | 2010 | 3 |
| 7 | 2013 | 3 | |
| 8 | Golimumab and Methotrexate combinatation therapy significantly improves synovitis, osteitis and bone erosion compared to Methotrexate alone - A magnetic resonance imaging study of Methotrexate-naïve rheumatoid arthritis patients | 2011 | 2 |
| 9 | Assessment of inflammation and damage by MRI in established RA patients with Methotrexate inadequate response receiving Golimumab: Results of the GO-FORWARD trial | 2011 | 2 |
| 10 | 2012 | 2 | |
| 11 | Improvement in DAS28 response through one-year of golimumab treatment in patients with active RA despite treatment with methotrexate: A phase II, randomized, double blind, placebo controlled, dose ranging trial | 2007 | 2 |
| 12 | 2016 | 2 | |
| 13 | 2013 | 2 | |
| 14 | 2013 | 2 | |
| 15 | PREDICTORS OF RADIOGRAPHIC PROGRESSION IN METHOTREXATE-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS BASED ON ONE-YEAR RADIOGRAPHIC DATA FROM THE GO-BEFORE GOLIMUMAB CLINICAL TRIAL | 2012 | 1 |
| 16 | Magnetic resonance imaging assessments of patients with RA and their association with clinical and radiographic outcomes | 2011 | 1 |
| 17 | GOLIMUMAB AND RADIOGRAPHIC PROGRESSION IN RHEUMATOID ARTHRITIS: RESULTS OF GO-BEFORE AND GO-FORWARD STUDIES | 2011 | 1 |
| 18 | GOLIMUMAB, A HUMAN TNF-ALPHA mu ONOCLONAL ANTIBODY, IN RHEUMATOID ARTHRITIS PATIENTS PREVIOUSLY TREATED WITH ANTI-TNF-ALPHA AGENTS (GO-AFTER STUDY) | 2009 | 1 |
| 19 | 2021 | 1 | |
| 20 | 2012 | 1 |
About E. C. Hsia
E. C. Hsia is a scholar working on Rheumatology, Genetics, Hematology, Immunology and Pathology and Forensic Medicine, having authored 35 papers that have together received 546 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (25 papers), Autoimmune and Inflammatory Disorders Research (7 papers), Chronic Lymphocytic Leukemia Research (7 papers), Psoriasis: Treatment and Pathogenesis (6 papers), Spondyloarthritis Studies and Treatments (6 papers), Systemic Lupus Erythematosus Research (6 papers), Acute Lymphoblastic Leukemia research (3 papers) and Autoimmune Bullous Skin Diseases (3 papers). The work is most often cited by research in Rheumatology (456 citations), Hematology (134 citations), Immunology (92 citations), Genetics (44 citations) and Radiology, Nuclear Medicine and Imaging (58 citations). E. C. Hsia has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Mahboob U. Rahman, Edward Keystone, Stephen Hall, Mark C. Genovese, Pedro C. Miranda, Sudha Visvanathan, William Palmer, Lars Klareskog, Maria Wiekowski and Julie Zrubek. Their work appears in journals such as Annals of the Rheumatic Diseases, Value in Health, Lara D. Veeken, Data Archiving and Networked Services (DANS) and DIAL (Catholic University of Leuven).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.